LEG vs PFE · rev $4.38B vs P/E 20, rev $15.03B
Leggett & Platt Incorporated (LEG) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Leggett & Platt Incorporated (LEG) is a furnishings, fixtures & appliances company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported LEG revenue for 2024-12-31 was $4.38B. Net income was -$511.4M. Revenue was down 7.2% from 2023-12-31 to 2024-12-31. LEG currently screens at market cap $1.34B.
Latest reported PFE revenue for 2026-06-28 was $15.03B. Net income was -$248.0M. Revenue was up 4.0% from 2026-03-29 to 2026-06-28. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
LEG currently screens at market cap $1.34B. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the LEG and PFE stock pages for the full models.
Not investment advice.